Avalon GloboCare Stock Forecast, Price & News

+0.05 (+5.36 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume222,113 shs
Average Volume119,118 shs
Market Capitalization$82.93 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AVCO News and Ratings via Email

Sign-up to receive the latest news and ratings for Avalon GloboCare and its competitors with MarketBeat's FREE daily newsletter.

Avalon GloboCare logo

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. It also has a collaboration agreement with the UPMC Hillman Cancer Center to advance the clinical development and production of CAR therapies using FLASH CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.24 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Avalon GloboCare (NASDAQ:AVCO) Frequently Asked Questions

What stocks does MarketBeat like better than Avalon GloboCare?

Wall Street analysts have given Avalon GloboCare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Avalon GloboCare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Avalon GloboCare?

Avalon GloboCare saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 1,080,000 shares, a decrease of 42.9% from the June 15th total of 1,890,000 shares. Based on an average daily trading volume, of 404,100 shares, the short-interest ratio is presently 2.7 days. Currently, 3.6% of the shares of the company are sold short.
View Avalon GloboCare's Short Interest

When is Avalon GloboCare's next earnings date?

Avalon GloboCare is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Avalon GloboCare

How were Avalon GloboCare's earnings last quarter?

Avalon GloboCare Corp. (NASDAQ:AVCO) issued its quarterly earnings results on Friday, May, 14th. The company reported ($0.03) EPS for the quarter. The company had revenue of $0.29 million for the quarter. Avalon GloboCare had a negative trailing twelve-month return on equity of 249.88% and a negative net margin of 858.86%.
View Avalon GloboCare's earnings history

How has Avalon GloboCare's stock been impacted by Coronavirus?

Avalon GloboCare's stock was trading at $1.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AVCO stock has decreased by 8.2% and is now trading at $0.9824.
View which stocks have been most impacted by COVID-19

What guidance has Avalon GloboCare issued on next quarter's earnings?

Avalon GloboCare updated its FY 2021 earnings guidance on Monday, July, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $5 million-$7 million.

Who are Avalon GloboCare's key executives?

Avalon GloboCare's management team includes the following people:
  • Dr. David K. Jin, CEO, Pres & Director (Age 53, Pay $360k)
  • Ms. Luisa Ingargiola, Chief Financial Officer (Age 53, Pay $350k)
  • Ms. Meng Li, COO, Sec. & Director (Age 43, Pay $340k)

Who are some of Avalon GloboCare's key competitors?

What other stocks do shareholders of Avalon GloboCare own?

What is Avalon GloboCare's stock symbol?

Avalon GloboCare trades on the NASDAQ under the ticker symbol "AVCO."

How do I buy shares of Avalon GloboCare?

Shares of AVCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avalon GloboCare's stock price today?

One share of AVCO stock can currently be purchased for approximately $0.98.

How much money does Avalon GloboCare make?

Avalon GloboCare has a market capitalization of $82.93 million and generates $1.38 million in revenue each year.

How many employees does Avalon GloboCare have?

Avalon GloboCare employs 6 workers across the globe.

What is Avalon GloboCare's official website?

The official website for Avalon GloboCare is

Where are Avalon GloboCare's headquarters?

Avalon GloboCare is headquartered at 4400 ROUTE 9 SUITE 3100, FREEHOLD NJ, 07728.

How can I contact Avalon GloboCare?

Avalon GloboCare's mailing address is 4400 ROUTE 9 SUITE 3100, FREEHOLD NJ, 07728. The company can be reached via phone at 732-780-4400 or via email at [email protected]

This page was last updated on 8/1/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.